| 96.71 Data as of 1:46pm ET |  -0.23 / -0.24%Today’s Change | 80.09 Today|||52-Week Range 102.04 | +4.91% Year-to-Date |
| Shire Rises On Unusually High Volume (SHPG) May 20 / TheStreet.com | 5 Drugs Stocks On The Rise May 20 / TheStreet.com |
| Previous close | 96.94 |
| Today’s open | 96.57 |
| Day’s range | 96.56 - 97.56 |
| Volume | 560,653 |
| Average volume (3 months) | 590,723 |
| Market cap | $17.9B |
| Dividend yield | 0.54% |
| Earnings growth (last year) | -14.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +9.69% |
| P/E ratio | NM |
| Price/Sales | 3.64 |
| Price/Book | 4.77 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | -0.21 | -0.26% |
| ACTActavis Inc | +0.34 | +0.26% |
| ZTSZoetis Inc | +0.42 | +1.27% |
| ALXNAlexion Pharmaceutic... | -1.72 | -1.68% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.64 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $746.8M |
| Net profit margin | 15.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Flemming Ørnskov, MD, MBA |
CFO, Director, CAO & Investor Relations Contact Graham C. Hetherington |
Corporate headquarters Dublin, -- |
.
